References
- American Academy of Pediatrics. Children’s hospital association. Children and COVID-19: State Data Report. 2022.
- ChildStats.gov. Child population: Number of children (in millions) ages 0–17 in the United States by age, 1950–2020 and projected 2021-2050 2020 [cited 2022 6 April]. Available from: https://www.childstats.gov/americaschildren/tables/pop1.asp.
- Sinha IP, Harwood R, Semple MG, et al. COVID-19 infection in children. Lancet Respir Med. 2020;8(5):446–447.
- US Centers for Disease Control and Prevention. Hospitalization of infants and children aged 0–4 years with laboratory-confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022, https://www.cdc.gov/mmwr/volumes/71/wr/mm7111e2.htm. Morbidity and Mortality Weekly Report (MMWR). 2022.
- Tso WWY, Wong RS, Tung KTS, et al. Vulnerability and resilience in children during the COVID-19 pandemic. Eur Child Adolesc Psychiatry. 2022;31(1):161–176.
- Flor LS, Friedman J, Spencer CN, et al. Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from march, 2020, to September, 2021. Lancet. 2022 Mar 2.
- Crotty S. Hybrid immunity. Science. 2021;372(6549):1392–1393.
- Walls AC, Sprouse KR, Bowen JE, et al. SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses. Cell. 2022;185(5):872–880.e3.
- Abdullah F, Myers J, Basu D, et al. Decreased severity of disease during the first global omicron variant COVID-19 outbreak in a large hospital in tshwane, South Africa. Int J Infect Dis. 2022;116:38–42.
- Brandal LT, MacDonald E, Veneti L, et al. Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021. Euro Surveill. 2021;26(50.
- Christensen PA, Olsen RJ, Long SW, et al. Signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with coronavirus disease 2019 caused by the Omicron variant of severe acute respiratory syndrome coronavirus 2 in houston, texas. Am J Pathol. 2022;192(4):642–652.
- Houhamdi L, Gautret P, Hoang VT, et al. Characteristics of the first 1119 SARS-CoV-2 Omicron variant cases, in marseille, France, November−December 2021. J Med Virol. 2022;94(5):2290–2295.
- Wang L, Berger NA, Kaelber DC, et al. Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of omicron. medRxiv. 2022 Jan 2.
- Wang L, Berger NA, Kaelber DC, et al. COVID infection severity in children under 5 years old before and after Omicron emergence in the US. medRxiv. 2022 Jan 13.
- Cloete J, Kruger A, Masha M, et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. Lancet Child Adolesc Health. 2022 Feb 18.
- Bhattacharyya RP, Hanage WP. Challenges in inferring intrinsic severity of the SARS-CoV-2 Omicron variant. N Engl J Med. 2022;386(7):e14.
- Lavine JS, Bjornstad ON, Antia R. Immunological characteristics govern the transition of COVID-19 to endemicity. Science. 2021;371(6530):741–745.
- Letter to Schools on “Arrangements on deferral of class resumption for all schools” (13 February 2020) [Internet]. 2020; 13 February [cited 10 May 2021]. https://www.edb.gov.hk/attachment/en/sch-admin/admin/about-sch/diseases-prevention/edb_20200213_eng.pdf.
- Arrangements of Early Commencement of Summer Holiday for All Schools [Internet]. (2020). 10 July [cited 10 May 2021]. https://www.edb.gov.hk/attachment/en/sch-admin/admin/about-sch/diseases-prevention/edb_20200505_eng.pdf.
- Continuation of Suspension of Face-to-Face Classes for Schools in Hong Kong: The Arrangements [Internet]. (2021). 4 January [cited 10 May 2021]. https://www.edb.gov.hk/attachment/en/sch-admin/admin/about-sch/diseases-prevention/edb_20210104_eng.pdf.
- Suspension of face-to-face classes of primary schools, kindergartens and kindergarten-cum-child care centres until Chinese New Year [Internet]. 2022; 11 January [cited 14 March 2022]. https://www.info.gov.hk/gia/general/202201/11/P2022011100677.htm.
- Letter to Kindergartens / Kindergarten-cum-Child Care Centres on “Arrangement of Special Vacation in the 2021/22 School Year” [Internet]. 2022; 28 February [cited 14 March 2022]. https://www.edb.gov.hk/attachment/en/sch-admin/admin/about-sch/diseases-prevention/edb_20220228_eng_d.pdf.
- HK Centre for Health Protection. Statistics. https://www.chp.gov.hk/en/static/24012.html#. 2022;2022.
- HK Centre for Health Protection. Detection of pathogens from respiratory specimens. https://www.chp.gov.hk/en/statistics/data/10/641/642/2274.html. 2022.
- HK Centre for Health Protection. COVID-19 Vaccination Programme. https://www.covidvaccine.gov.hk/en/dashboard. 2022;2022(12 February).
- Cheng VC, Ip JD, Chu AW, et al. Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak. Clin Infect Dis. 2022 Mar 10.
- Wang L, Berger NA, Kaelber DC, et al. COVID infection rates, clinical outcomes, and racial/ethnic and gender disparities before and after Omicron emerged in the US. medRxiv. 2022 Feb 22.
- Marks KJ, Whitaker M, Anglin O, et al. Hospitalizations of children and adolescents with laboratory-confirmed COVID-19 — COVID-NET, 14 states, July 2021–January 2022. MMWR Morb Mortal Wkly Rep. 2022;71(7):271–278.
- Ludvigsson JF. Convulsions in children with COVID-19 during the Omicron wave. Acta Paediatr. 2022 Jan 31.
- Tunc EM, Shin CKJ, Usoro E, et al. Croup during the COVID-19 Omicron variant surge. medRxiv. 2022: 2022.02.02.22270222.
- Brewster RCL, Parsons C, Laird-Gion J, et al. COVID-19-associated croup in children. Pediatrics. 2022 Mar 8.
- Murata Y, Tomari K, Matsuoka T. Children with croup and SARS-CoV-2 infection during the large outbreak of omicron. Pediatr Infect Dis J. 2022 Feb 17.
- Robinson ML, Morris CP, Betz J, et al. Impact of SARS-CoV-2 variants on inpatient clinical outcome. medRxiv. 2022 Feb 3.
- Sing CW, Woo YC, Lee ACH, et al. Validity of major osteoporotic fracture diagnosis codes in the clinical data analysis and reporting system in Hong Kong. Pharmacoepidemiol Drug Saf. 2017;26(8):973–976.
- Chua GT, Wong JSC, Lam I, et al. Clinical characteristics and transmission of COVID-19 in children and youths during 3 waves of outbreaks in Hong Kong. JAMA Netw Open. 2021;4(5):e218824.
- HK Centre for Health Protection. https://www.coronavirus.gov.hk. Hong Kong 2022.
- Sun JW, Bourgeois FT, Haneuse S, et al. Development and validation of a pediatric comorbidity index. Am J Epidemiol. 2021;190(5):918–927.
- HK Centre for Health Protection. Seasonal Influenza. https://www.chp.gov.hk/en/features/14843.html. 2021.
- Fink EL, Robertson CL, Wainwright MS, et al. Prevalence and risk factors of neurologic manifestations in hospitalized children diagnosed with acute SARS-CoV-2 or MIS-C. Pediatr Neurol. 2022;128:33–44.
- Ray STJ, Abdel-Mannan O, Sa M, et al. Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study. Lancet Child Adolesc Health. 2021;5(9):631–641.
- Hui KPY, Ho JCW, Cheung MC, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022 Feb 1.
- Nyberg T, Ferguson NM, Nash SG, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022 Mar 16.
- Ng KW, Faulkner N, Cornish GH, et al. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020;370(6522):1339–1343.
- Kundu R, Narean JS, Wang L, et al. Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Nat Commun. 2022;13(1):80.
- Swadling L, Diniz MO, Schmidt NM, et al. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature. 2022;601(7891):110–117.
- HK Centre for Health Protection. CHP Newsletter, https://www.chp.gov.hk/files/pdf/chp50_en.pdf. 2022 (50).
- news.gov.hk. HK sees 25k COVID-19 cases (Chinese Version only) 2022 [updated 7 March 2022; cited 2022 6 April]. Available from: https://www.news.gov.hk/chi/2022/03/20220307/20220307_180507_220.html.
- HK Centre for Health Protection. Archives of latest situation of cases of COVID-19. https://www.chp.gov.hk/en/features/102997.html. 2022.
- Census and Statistics Department of the HKSAR. Hong Kong Annual Digest of Statistics (2021 Edition). Hong Kong2021.
- Chiu SS, Kwan MYW, Feng S, et al. Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a prolonged season, 2016/2017. J Infect Dis. 2018;217(9):1365–1371.
- Chiu SS, Kwan MYW, Feng S, et al. Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18. Euro Surveill. 2018 Feb;23(8.
- Lau YL, Wong WHS, Hattangdi-Haridas SR, et al. Evaluating impact of school outreach vaccination programme in Hong Kong influenza season 2018 - 2019. Hum Vaccin Immunother. 2020;16(4):823–826.
- Lauring AS, Tenforde MW, Chappell JD, et al. Clinical severity of, and effectiveness of mRNA vaccines against, COVID-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. Br Med J. 2022 Mar 9;376:e069761.
- Andrews N, Stowe J, Kirsebom F, et al. COVID-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022 Mar 2.
- Walter EB, Talaat KR, Sabharwal C, et al. Evaluation of the BNT162b2 COVID-19 vaccine in children 5 to 11 years of Age. N Engl J Med. 2022;386(1):35–46.
- Jara A, Undurraga EA, González C, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med. 2021;385(10):875–884.
- Lau Y-L, Duque JR, Wang X, et al. Immunogenicity and reactogenicity of SARS-CoV-2 mRNA and inactivated vaccines in healthy adolescents. Nat Commun. 2022: in press.
- UK Joint Committee on Vaccination and Immunisation (JCVI). JCVI statement on vaccination of children aged 5 to 11 years old. https://www.gov.uk/government/publications/jcvi-update-on-advice-for-covid-19-vaccination-of-children-aged-5-to-11/jcvi-statement-on-vaccination-of-children-aged-5-to-11-years-old. 2022.
- US Centers for Disease Control and Prevention. COVID-19 vaccines for children and teens. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/children-teens.html?CDC_AA_refVal=https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/adolescents.html. 2022.
- International League Against Epilepsy. COVID-19 vaccines and people with epilepsy. https://www.ilae.org/patient-care/covid-19-and-epilepsy/covid-19-vaccines-and-people-with-epilepsy. 2022.